Skip to content

Bristol-Myers Squibb BMY Total costs & expenses

Total costs & expenses at other companies

Incyte logo
IncyteINCY
Gilead Sciences logo
Gilead SciencesGILD
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Amgen logo
AmgenAMGN
Royalty Pharma logo
Royalty PharmaRPRX
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$11.5B+2.6%
Gross profit$8.1B-1.2%
Net income$2.7B+9.0%
EPS (diluted)$1.31+9.2%

Balance sheet

See full
Cash & equivalents$9.6B-12.0%
Total debt$44.7B-10.5%
Total equity$20.1B+15.4%
Total assets$86.5B-6.4%

Cash flow

See full
Operating cash flow$1.1B-43.5%
CapEx$347.0M+33.5%
Free cash flow$757.0M-55.3%

Valuation

See full
Market cap$112.89B-0.2%
Enterprise value$147.97B-2.6%
P/E15.5×-5.6×
P/S2.3×0.0×

Profitability

See full
Gross margin70.5%0.0pp
Net margin15%+3.8pp

Returns & leverage

See full
Return on equity38.8%+7.3pp
Debt / equity2.2×-0.6×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Bristol-Myers Squibb in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bristol-Myers Squibb's total costs & expenses?
Bristol-Myers Squibb (BMY) reported total costs & expenses of $8.25B in Q1 2026.
How has Bristol-Myers Squibb's total costs & expenses changed year-over-year?
Bristol-Myers Squibb's total costs & expenses increased by 0.2% year-over-year, from $8.23B to $8.25B.
What is the long-term trend for Bristol-Myers Squibb's total costs & expenses?
Over 4 years (2021 to 2025), Bristol-Myers Squibb's total costs & expenses has grown at a 0.4% compound annual growth rate (CAGR), from $38.29B to $38.87B.